番茄社区

Selected highlights from the 2024 American College of Gastroenterology annual meeting

Rifaximin also reduced mortality, but its high cost may be a barrier

At scale, the benefits of AI-assisted colonoscopy may not always outweigh the costs

Monoclonal antibody cendakimab also reduced eosinophils compared with placebo

Patients also found MoviPrep to be more tolerable and were more willing to repeat it

The drug also met primary endpoint of reducing peak esophageal intraepithelial eosinophil counts

But conservative management used in most cases

ColoSense test outperforms fecal immunochemical testing in phase III trial

Relationship was seen across the different types of blood thinners

Researchers strongly discourage its use in IBD patients

Most endoscopists reported having back, neck, and hand pain

Disease control also maintained with temporary withdrawal, at least initially

ECOSPOR IV study found low recurrence regardless of the number of prior episodes

U-ENDURE trial also hit co-primary endpoint for endoscopic response